Unichem Laboratories Limited's board approved the following in its meeting held on 28 Mar 25:

• Transfer of 100% stake in its wholly-owned subsidiary, Unichem Laboratories Limited, Ireland (“Unichem Ireland”), to its parent company, Ipca Laboratories Limited. The paid-up share capital of Unichem Ireland is Rs. 24.85 crores, and its accumulated losses are Rs. 25.32 crores. The total sales of Unichem Ireland for FY 2023-24 were Rs. 8.13 crores, constituting 0.47% of Unichem India's consolidated revenue. Sales up to February 2025 were Rs. 8.71 crores. The consideration to be received is Rs. 4.00 crores. The transaction is expected to be completed on or before 30 Apr 25.
• Proposal to close the manufacturing facility of its wholly-owned subsidiary, Niche Generics Limited (“Niche UK”), located at Baldoyle, Dublin, Ireland. The turnover of the plant for FY 2023-24 was Rs. 37.57 crores, representing 2.20% of Unichem India's consolidated turnover. The closure is expected to be completed by around Q1 of FY 2025-26 due to continuous losses and high operational costs. The lease period of the premises is also coming to an end in FY 2026-27. Unichem India will continue to manufacture the products from its Indian facilities.